STOCK TITAN
  1. Home
  2. BSTC

Biospecifics Stock Price, News & Analysis

BSTC NASDAQ

Company Description

Biospecifics (NASDAQ: BSTC) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

BSTC stock has gained 61.4% over the past year.

This page provides a comprehensive overview of BSTC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+61.37%
Performance 1 year
$0.0
Market Cap
7.3M
Shares outstanding

Biospecifics (BSTC) stock. Over the past 12 months, the stock has gained 61.4%.

Latest News

View All
—

BioSpecifics Announces Completion of Acquisition by Endo Pharmaceuticals

acquisition
+0.08%

Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer

0.00%

BioSpecifics Reports Third Quarter 2020 Financial and Operating Results

earnings
+0.09%

Endo International plc Commences Tender Offer for All Outstanding Shares of BioSpecifics Technologies Corp.

+45.35%

BioSpecifics to be Acquired by Endo Pharmaceuticals

acquisition
+45.35%

Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™

acquisition

Biospecifics has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings, conferences, management. View all BSTC news →

SEC Filings

View All

No SEC filings available for BSTC.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

BSTC Company Profile & Sector Positioning

Biospecifics (BSTC) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.